A tighter archive for life-science signals.
Search once, then narrow by source or topic.
White House frustration may have fueled FDA’s Moderna walkback: Politico
White House frustration may have fueled FDA’s Moderna walkback: Politico
FDA accepts filing for Moderna flu vaccine after swift rethink
FDA accepts filing for Moderna flu vaccine after swift rethink
With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment
With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment
Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg
Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg
UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing
UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing
Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale
Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale
Chutes & Ladders—Moderna CMO steps down in leadership mix-up
Chutes & Ladders—Moderna CMO steps down in leadership mix-up
Moderna's latest CMO steps down after barely a year
Moderna's latest CMO steps down after barely a year
Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials
Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials
Merck-Moderna cancer vaccine sustains 49% melanoma risk reduction at 5 years
Merck-Moderna cancer vaccine sustains 49% melanoma risk reduction at 5 years
After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vaccine into phase 3
After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vaccine into phase 3
<a href="https://www.fiercebiotech.com/biotech/modernas-reshaping-rolls-3-more-pipeline-purges" hreflang="en">Moderna's reshaping rolls on with 3 more pipeline purges</a>
Moderna, an mRNA specialist known for its COVID-19 vaccine Spikevax, is winding down development of three clinical mRNA programs, including two investigational vaccines...
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page